Surgical pathological staging of breast cancer by sentinel lymph node biopsy with specia/emphasis on the histological work-up of axillary sentinel lymph nodes

Breast Cancer

Volumn 11, Issue 3, 2004, Pages 242-249

  Csemi, Gábor ^a  

^a BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

Breast Cancer; Histopathology; Sentinel lymph node

Indexed keywords

BREAST TUMOR; CANCER STAGING; CLASSIFICATION; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; PATHOLOGY; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 16644398047     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02984544     Document Type: Review

References (78)

1. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ: Prognostic factors in breast cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 124:966-978, 2000.
2. Fisher B, Slack NH: Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet 131:79-88, 1970.
3. Reynolds JV, Mercer P, McDermot EWM, Cross S, Stokes M, Murphy D, O'Higgins NJ: Audit of complete axillary dissection in early breast cancer. Eur J Cancer 30A:148-149, 1994. (Pubitemid 24081277)
4. Cserni G: How to improve lymph node recovery rates fl'om axillary clearance specimens of breast cancer? A short-term audit. J Clin Pathol 51:846-849, 1998. (Pubitemid 28530849)
5. Cady B: Total mastectomy and partial axillary dissection. Surg Clin North Am 53:313-318, 1973.
6. Boova RS, Bonanni R, Rosato FE: Patterns of axillary nodal involvement in breast cancer. Ann Surg 196:642-644, 1982.
7. Forrest APM, Roberts MM, Cant E, Shivas AA: Simple mastectomy and pectoral node biopsy. Br J Surg 63:569-575, 1976.
8. Steele RJC, Forrest APM, Gibson T, Stewart HJ, Chetty U: The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. BrJ Surg 72:368-369, 1985. (Pubitemid 15034708)
9. Kificuta CI, Tausch J: A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 69:2496-2501, 1992.
10. Wilking N, Rutquist LE, Carstensen J, Mattsson A, Skoog L, and participating members of the Stockholm Breast Cancer Study Group: Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Onco131:29-35, 1992.
11. Vinh-Hung V, Cserni G, Burzykowski T, Van de Steene J, Voordeckers M, Storme G: Effect of the number of uninvolved nodes on survival in early breast cancer. Oncol Rep 10:363-369, 2003.
12. Cserni G: The reliability of sampling 3 to 6 nodes for staging breast cancer. J Clin Patho152:681-683, 1999. (Pubitemid 29456905)
13. Sato K, Tamaki K, Takeuchi H, Tsuda H, Kosuda S, Kusano S, Hiraide H, Mochizuki H: Management of the axilla in breast cancer: a comparative study between sentinel lymph node biopsy and four-node sampling procedure. Jpn J Clin Oncol 31:318-321, 2001. (Pubitemid 32791459)
14. Ahlgren J, Holmberg L, Bergh J, Liljegren G: Fivenode biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Eur J Surg Onco128:97-102, 2002. (Pubitemid 35023648)
15. Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-340, 1993. (Pubitemid 24019852)
16. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398, 1994.
17. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822, 1996. (Pubitemid 26406231)
18. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Wells CA: Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39:1654-1667, 2003. (Pubitemid 36897601)
19. Schrenk P, Rieger R, Shamiyeh A, Wayand W: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608-614, 2000. (Pubitemid 30056936)
20. Haid A, Kuehn T, Konstantiniuk P, Koberle-Wuhrer R, Knauer M, Kreienberg R, Zimmermann G: Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Onco128:705-710, 2002. (Pubitemid 36240568)
21. Rahusen FD, Pijpers R, Van Diest PJ, Bleichrodt RP, Torrenga H, Meijer S: The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery 128:6-12, 2000. (Pubitemid 30456888)
22. Noguchi M: Sentinel lymph node biopsy in breast cancer: an overview of the Japanese experience. Breast Cancer 8:184-194, 2001.
23. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinelnode biopsy with routine axillary dissection in breast cancer. N EnglJ Med 349:546-553, 2003. (Pubitemid 36951366)
24. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 180:700-704, 1995.
25. Saphir O, Amromin GD: Obscure axillary lymph node metastasis in carcinoma of the breast. Cancer 1:238-241, 1948.
26. Pickren JW: Significance of occult metastases - a study of breast cancer. Cancer 14:1266-1271, 1961.
27. Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B: Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 42:2025-2031, 1978. (Pubitemid 9055971)
28. Wilkinson EJ, Hause LL, Hoffman RG, Kuzma JF, Rothwell DJ, Donegan WL, Clowry LJ, Almagro UA, Choi H, Rimm AA: Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. PathoIAnn 17:67-91, 1982.
29. Wells CA, Heryet A, Brochier J, Gatter KC, Mason DY: The immunocytochemical detection of axillary micrometastases in breast cancer. BrJ Cancer 50:193-197, 1984. (Pubitemid 14061944)
30. Trojani M, Mascarel ID, Bonichon F, Coindre JM, Delsol G: Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 55:303-306, 1987. (Pubitemid 17036845)
31. Sedmak D, Meineke T, Knechtges D, Anderson J: Prognostic significance of cytokerafin-positive breast cancer metastases. Mod Pathol 2:516-520, 1989.
32. Apostolikas N, Petrai C, Agnantis NJ: The reliability of histologically negative axillary lymph nodes in breast cancer. Path Res Pract 184:35-38, 1989. (Pubitemid 19017572)
33. International Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335:1565-1568, 1990.
34. Galea M, Athanassiou E, Bell J, Dilks B, Robertson JFR, Elston CW, Blamey RW, Ellis IO: Occult regional lymph node metastases from breast carcinoma: immunohistochemical detection with antibodies CAM 5.2 and NCRC-11.J Pathol 165:221-227, 1991.
35. De Mascarel I, Bonichon F, Coindre J, Trojani M: Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66:523-527, 1992.
36. Zhang PJ, Reisner RM, Nangia R, Edge SB, Brooks JJ: Effectiveness of multiple-level sectioning in detecting axillary nodal micrometastasis in breast cancer. Arch Pathol Lab Med 122:687-690, 1998.
37. Turner RR, Ollila DW, Krasne DL, Giuliano AE: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226:271-276, 1997.
38. Sabel MS, Zhang P, Barnwell JM, Winston JS, Hurd TC, Edge SB: Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma. J Surg Onco177:243-246, 2001. (Pubitemid 32744192)
39. Stitzenberg KB, Calvo BF, Iacocca MV, Neelon BH, Sansbury LB, Dressler LG, Ollila DW: Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol 117:729-737, 2002. (Pubitemid 34457007)
40. Czerniecki BJ, Scheff AM, Callans LS, Spitz FR, Bedrosian I, Conant EF, Orel SG, Berlin J, Helsabeck C, Fraker DL, Reynolds C: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85:1098-1103, 1999. (Pubitemid 29115589)
41. Silverberg SG: Sentinel node processing. Recommendations for pathologists. Am J Surg Pathol 26:383-385, 2002. (Pubitemid 34184464)
42. Schwartz GF, Giuliano AE, Veronesi U, the Consensus Conference Committee: Proceedings of the Consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol 33:579-589, 2002. (Pubitemid 34827538)
43. Kollias J, Gill PG, Chatterton B, Raymond W, Collins PJ: Sentinel node biopsy in breast cancer: recommendations for surgeons, pathologists, nuclear physicians and radiologists in Australia and New Zealand. Aust N ZJ Surg 70:132-136, 2000. (Pubitemid 30136796)
44. Osterreichischen Gesellschaft fur Pathologie: http:#www.pathology.at/ sentinel.htm (Assessed october 2003).
45. van Diest PJ: Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol 52:871-873, 1999. (Pubitemid 30005357)
46. Weaver DL: Sentinel lymph nodes and breast carcinoma. Am J Surg Patho127:842-845, 2003.
47. Turner RR, Ollila D, Stern S, Giuliano AE: Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 23:263-267, 1999. (Pubitemid 29117560)
48. Hoda SA, Gift D, Chiu A: Examining the sentinel lymph node. Am J Surg Patho124:307, 2000.
49. Hoda SA, Chiu A, Resetkova E, Harigopal M, Hoda RS, Osborne MP: Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions. Microscopy Research and Technique 59:85-91, 2002. (Pubitemid 35154910)
50. Cserni G: Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work-up. J Clin Patho152:922-924, 1999. (Pubitemid 30005368)
51. Torrenga H, Rahusen FD, Meijer S, Borgstein PJ, van Diest PJ: Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Patho154:550-552, 2001. (Pubitemid 32642945)
52. Cserni G: Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 55:926-931, 2002. (Pubitemid 35454495)
53. Yared MA, Middleton LP, Smith TL, Kim HW, Ross MI, Hunt KK, Sahin AA: Recommendations for Sentinel Lymph Node Processing in Breast Cancer. Am J Surg Patho126:377-382, 2002. (Pubitemid 34184463)
54. Cserni G: Sentinel lymph node histopathology in breast cancer. Letter. AmJ Surg Patho126:1368, 2002.
55. Sobin LH, Wittekind C, eds, UICC TNM classification of malignant tumours, 6th ed, John Wiley and Sons, New York, 2002.
56. Cserni G: Mapping metastases in sentinel lymph nodes of breast cancer. Am J Clin Pathol 113:351-354, 2000. (Pubitemid 30217381)
57. Diaz LK, Hunt K, Ames F, Meric F, Kuerer H, Babiera G, Ross M, Singletary E, Middleton LP, Symroans WF, Krishnamurthy S, Sahin A, Sneige N, Gilcrease MZ: Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol 27:385-389, 2003. (Pubitemid 36245804)
58. Dowlatshahi K, Fan M, Snider HC, Habib FA: Lymph node micrometastases from breast carcinoma. Reviewing the dilemma. Cancer 80:1188-1197, 1997. (Pubitemid 27407219)
59. American Joint Committee on Cancer: Breast. In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Hailer DG, Morrow M, eds, AJCC Cancer staging handbook, 6th ed, Springer Verlag, New York, 155-181, 2002.
60. Ishikawa H, Sato K, Mochizuki H: Optimal sentinel node examination and a new strategy for axillary control in breast cancer. BreastJ 8:10-14, 2002. (Pubitemid 34118478)
61. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE: Do all patients with sentinel node metastasis from breast carcinoma need complete axiUary node dissection? Ann Surg 229:536-541, 1999. (Pubitemid 30191752)
62. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, Orel SG, Keeney GL, Lawton TJ, Czerniecki BJ: Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17:1720-1726, 1999. (Pubitemid 29269240)
63. Cserni G: Sentinel lymph node biopsy-based prediction of further breast cancer metastases in the axilla. Eur J Surg Onco127:532-538, 2001. (Pubitemid 32842722)
64. Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A, Renne G, Pruneri G, Maisonneuve P, Veronesi U: Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92:1378-1384, 2001. (Pubitemid 32947820)
65. Cserni G, Rajtar M, Boross G, Sinkó M, Svébis M, Baltfis B: Comparison of vital dye-guided lymphatic mapping and dye plus gamma probe-guided sentinel node biopsy in breast cancer. World J Surg 26:592-597, 2002. (Pubitemid 36920373)
66. Cserni G, Boross G, Baltfis B: Value of axillary sentinel nodal status in breast cancer. World J Surg 24:341-344, 2000. (Pubitemid 30117764)
67. Cserni G, Rajtfir M, Boross G: Blue nodes left behind after vital blue dye-guided axillary sentinel node biopsy in breast cancer patients. Jpn J Clin Oncol 30:263-266, 2000. (Pubitemid 30628100)
68. Cserni G, Boross G, Rajtfir M, Sinká M, Marfiz R, Svébis M, Baltfis B, Ambrózay E: Sentinel node biopsy: learning, validating and introducing as standard of care. EurJ Cancer 38 (Supp13):S64, 2002.
69. Cserni G, Pap Szekeres J: Internal mammary lymph nodes and sentinel node biopsy in breast cancer. Surg Oncol 10:25-33, 2001. (Pubitemid 33086837)
70. Noguchi M: Relevance and practicability of internal mammary sentinel node biopsy for breast cancer. Breast Cancer 9:329-336, 2002.
71. Noguchi M: Internal mammary sentinel node biopsy for breast cancer: is it practicable and relevant? Oncol Rep 9:461-468, 2002.
72. Sugg SL, Ferguson DJ, Posner MC, Heimann R: Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol 7:188-192, 2002.
73. Cserni G: The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients. Am Surg 67:86-91, 2001. (Pubitemid 33638501)
74. Cserni G: The effect of increasing the surface sampled by imprint cytology on the intraoperative assessment of axillary sentinel lymph nodes in breast cancer patients. Am Surg 69:419-423, 2003.
75. Fréneanx P, Nos C, Vincent-Salomon A, Genin P, Sigal-Zafrani B, AI Ghuzlan A, Birolini MJ, Clough K, Sastre-Garau X: Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice. Mod Pathol 15:641-646, 2002. (Pubitemid 34666468)
76. Noguchi M: Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary dissection? Breast Cancer 10:179-187, 2003.
77. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez- Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Fejes G, Wells CA: Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire-based survey by the European Working Group for Breast Screening Pathology. J Clin Patho157:695-701, 2004. (Pubitemid 38901482)
78. Cserni G: A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Patho157:467-471, 2004. (Pubitemid 38621790)